Efficacy and safety of TRPV1-related preparations in the treatment of inflammatory arthralgia

BACKGROUND: Currently, medications for the treatment of inflammatory arthralgia are limited. The role and safety of transient receptor potential vanilloid subtype 1 (TRPV1)-related preparations in reducing inflammatory arthralgia have not yet been fully established. Thus, we aimed to review the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xin, Li, Ziping, Xing, Bingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681444/
https://www.ncbi.nlm.nih.gov/pubmed/38013379
http://dx.doi.org/10.1097/MD.0000000000036268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681444/
https://www.ncbi.nlm.nih.gov/pubmed/38013379
http://dx.doi.org/10.1097/MD.0000000000036268

Ejemplares similares